With CRP as a biomarker of systematic inflammation, however, CRP-POCT enables clinicians to discern bacterial infections from other inflammatory disorders and helps them to identify the patients who benefit the most from antibiotics [21]. This evidence concerns the gene CRP and bacterial infectious disease.